124 related articles for article (PubMed ID: 8392157)
21. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
Kalivas PW; Duffy P
J Pharmacol Exp Ther; 1987 Apr; 241(1):204-12. PubMed ID: 3572784
[TBL] [Abstract][Full Text] [Related]
22. Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice.
Kuzmin A; Sandin J; Terenius L; Ogren SO
J Pharmacol Exp Ther; 2000 Dec; 295(3):1031-42. PubMed ID: 11082438
[TBL] [Abstract][Full Text] [Related]
23. Effect of food restriction on cocaine locomotor sensitization in Sprague-Dawley rats: role of kappa opioid receptors.
Allen CP; Zhou Y; Leri F
Psychopharmacology (Berl); 2013 Apr; 226(3):571-8. PubMed ID: 23212389
[TBL] [Abstract][Full Text] [Related]
24. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
[TBL] [Abstract][Full Text] [Related]
25. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
Mellon RD; Bayer BM
Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
[TBL] [Abstract][Full Text] [Related]
26. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.
Heidbreder CA; Goldberg SR; Shippenberg TS
Brain Res; 1993 Jul; 616(1-2):335-8. PubMed ID: 8395306
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.
Carr KD; Kutchukhidze N; Park TH
Brain Res; 1999 Mar; 822(1-2):34-42. PubMed ID: 10082881
[TBL] [Abstract][Full Text] [Related]
28. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
Tsuji M; Takeda H; Matsumiya T; Nagase H; Narita M; Suzuki T
Life Sci; 2001 Mar; 68(15):1717-25. PubMed ID: 11270618
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappa-opioid receptors.
Shu H; Arita H; Hayashida M; Chiba S; Sekiyama H; Hanaoka K
J Ethnopharmacol; 2006 Jun; 106(2):263-71. PubMed ID: 16446067
[TBL] [Abstract][Full Text] [Related]
30. Endogenous central kappa-opioid systems augment renal sympathetic nerve activity to maximally retain urinary sodium during hypotonic saline volume expansion.
Gottlieb HB; Kapusta DR
Am J Physiol Regul Integr Comp Physiol; 2005 Nov; 289(5):R1289-96. PubMed ID: 15976307
[TBL] [Abstract][Full Text] [Related]
31. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
Spanagel R; Almeida OF; Shippenberg TS
Eur J Pharmacol; 1994 Oct; 264(2):157-62. PubMed ID: 7851478
[TBL] [Abstract][Full Text] [Related]
32. Increased release of excitatory amino acids in rat locus coeruleus in kappa-opioid agonist dependent rats precipitated by nor-binaltorphimine.
Hoshi K; Ma T; Oh S; Ho IK
Brain Res; 1997 Apr; 753(1):63-8. PubMed ID: 9125432
[TBL] [Abstract][Full Text] [Related]
33. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
Cui CL; Wu LZ; Han JS
Neurosci Lett; 2000 Dec; 295(1-2):45-8. PubMed ID: 11078933
[TBL] [Abstract][Full Text] [Related]
34. The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.
Chen X; McClatchy DB; Geller EB; Tallarida RJ; Adler MW
Life Sci; 2005 Dec; 78(4):329-33. PubMed ID: 16257420
[TBL] [Abstract][Full Text] [Related]
35. Long term kappa-opioid receptor blockade following nor-binaltorphimine.
Jones DN; Holtzman SG
Eur J Pharmacol; 1992 May; 215(2-3):345-8. PubMed ID: 1327807
[TBL] [Abstract][Full Text] [Related]
36. Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.
Zhang Y; Butelman ER; Schlussman SD; Ho A; Kreek MJ
Psychopharmacology (Berl); 2004 Apr; 173(1-2):146-52. PubMed ID: 14712342
[TBL] [Abstract][Full Text] [Related]
37. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
Takemori AE; Schwartz MM; Portoghese PS
J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
[TBL] [Abstract][Full Text] [Related]
38. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
39. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
Shippenberg TS; LeFevour A; Heidbreder C
J Pharmacol Exp Ther; 1996 Feb; 276(2):545-54. PubMed ID: 8632320
[TBL] [Abstract][Full Text] [Related]
40. Effects of the kappa-opioid agonist U50,488 on parturition in rats.
Douglas AJ; Clarke G; MacMillan SJ; Bull PM; Neumann I; Way SA; Wright DM; McGrory BG; Russell JA
Br J Pharmacol; 1993 May; 109(1):251-8. PubMed ID: 8388299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
